| Date Filed | Type | Description |
| 07/12/2023 |
4
| SCHADE CHRISTIAN S (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 36,713 options to buy
@ $4.69, valued at
$172.2k
|
|
| 07/12/2023 |
3
| SCHADE CHRISTIAN S (Director) has filed a Form 3 on Omega Therapeutics, Inc. |
| 06/09/2023 |
4
| Boehm Rainer J. (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| Levy Elliott M. (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/09/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 03/20/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $8, valued at
$80k
|
|
| 03/02/2023 |
4
| Moore Yan (Chief Medical Officer) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 03/02/2023 |
4
| McManus Kevin (Chief Human Resources Officer) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 03/02/2023 |
4
| Karande Mahesh (President and CEO) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $6.46, valued at
$1.1M
|
|
| 03/02/2023 |
4
| Zeng Ling (See Remarks) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 03/02/2023 |
4
| Reed Joshua (CFO) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 03/02/2023 |
4
| McCauley Thomas (Chief Scientific Officer) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 02/27/2023 |
4
| Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Bought 1,993,986 shares
@ $5.78, valued at
$11.5M
Bought 1,329,324 shares
@ $5.78, valued at
$7.7M
|
|
| 02/27/2023 |
3
| Flagship Pioneering Fund VII General Partner LLC (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc. |
| 01/11/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $8, valued at
$160k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $8, valued at
$80k
|
|
| 09/01/2022 |
4
| Boehm Rainer J. (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 36,713 options to buy
@ $4.47, valued at
$164.1k
|
|
| 09/01/2022 |
3
| Boehm Rainer J. (Director) has filed a Form 3 on Omega Therapeutics, Inc. |
| 06/10/2022 |
4
| Levy Elliott M. (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
| 06/10/2022 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
| 06/10/2022 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
| 06/10/2022 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
| 06/10/2022 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
| 06/10/2022 |
4
| Szela Mary T (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $3.31, valued at
$60k
|
|
|